Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Ventricular Dysfunction, Left: later-stage trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Ventricular Dysfunction, Left: 3 US clinical trials tracked, none currently recruiting.
Ventricular Dysfunction, Left is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is BioVentrix, running 1 of these trials.
Enrollment posture brief
Registry condition ventricular-dysfunction-left
OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Ventricular Dysfunction, Left has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Ventricular Dysfunction, Left on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Ventricular Dysfunction, Left is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
BioVentrix Revivent TC™ System Clinical Study
BioVentrix
NCT02931240
Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
GE Healthcare
NCT01936649
Characterization of the Plasma Proteome Following Left Ventricular Assist Device Implantation
University of Colorado, Denver
NCT02428894
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Ventricular Dysfunction, Left records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Ventricular Dysfunction, Left trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Ventricular Dysfunction, Left page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Ventricular Dysfunction, Left trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- BioVentrix sponsors the most Ventricular Dysfunction, Left trials on record, review their full trial history before evaluating a specific study. See BioVentrix's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Ventricular Dysfunction, Left condition card totals 3 registered trials; most-linked intervention AdreView (Iobenguane I 123 Injection); top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.